To the editor

JAMA - Journal of the American Medical Association

Volumn 316, Issue 4, 2016, Pages 455-

  Jaehne, Anja Kathrin ^a   Jayaprakash, Namita ^b   Langberg, Sam ^a  

^a HENRY FORD HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR; LACTIC ACID;

BLOOD PRESSURE MEASUREMENT; DATA BASE; FLUID RESUSCITATION; HUMAN; HYPOTENSION; LACTATE BLOOD LEVEL; LETTER; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; CONSENSUS; SHOCK, SEPTIC;

CONSENSUS; HUMANS; SHOCK, SEPTIC;

EID: 84982947925     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.6140     Document Type: Letter

References (5)

1. Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock. JAMA. 2016;315(8):775-787.
2. Wacharasint P, Nakada TA, Boyd JH, Russell JA, Walley KR. Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock. 2012;38(1):4-10.
3. Thomas-Rueddel DO, Poidinger B, Weiss M, et al. Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock. J Crit Care. 2015;30(2):439.e1-439.e6.
4. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19): 1368-1377.
5. Angus DC, Barnato AE, Bell D, et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock. Intensive Care Med. 2015;41(9): 1549-1560.